DHR vs EBS · P/E 39, rev $24.57B vs rev $1.04B
Danaher Corporation (DHR) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. EBS currently screens at market cap $416.4M.
Not investment advice. Open the DHR and EBS stock pages for the full models.
Not investment advice.